MedTrace Logo

Heparin Binding Protein in Early Sepsis Diagnosis

NCT03295825 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2018-10-23

No results posted yet for this study

Summary

The primary objective of this study is to use heparin-binding protein (HBP) concentration to indicate the presence, or outcome, of sepsis over 72 hours after ED admission. The secondary objectives of this study are to separately evaluate the performance of HBP to predict outcome in patients with suspected infection over 12-24 hours after ED admission.

Conditions

Interventions

DIAGNOSTIC_TEST

Biomarker

Measument of heparin-binding protein in the serum of patients

Sponsors & Collaborators

  • National and Kapodistrian University of Athens

    collaborator OTHER

  • Aristotle University Of Thessaloniki

    collaborator OTHER

  • Hellenic Institute for the Study of Sepsis

    lead OTHER

Principal Investigators

  • Evangelos Giamarellos-Bourboulis, MD, PhD · National and Kapodistrian University of Athens

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-22
Primary Completion
2018-06-30
Completion
2018-09-30

Countries

  • Greece

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03295825 on ClinicalTrials.gov